文献速递临床试验与 GCP

门诊球囊导管与住院前列腺素用于引产的随机对照试验(OBLIGE)

Outpatient balloon catheter vs inpatient prostaglandin for induction of labour (OBLIGE): a randomised controlled trial.
PubMed 文献 · Trials · 2020-02-17

OBLIGE是一项新西兰多中心随机对照试验,纳入足月单胎头位计划引产的孕妇,比较门诊单球囊导管引产与住院阴道前列腺素E2引产的剖宫产率、安全性与成本效果。研究拟以80%把握度、5%一类错误检出剖宫产率从24.8%基线相对下降24%,需1552例受试者。

要点

  • 比较门诊球囊导管与住院前列腺素E2引产的剖宫产率。
  • 主要结局为剖宫产率,计划样本量1552例。
  • 若有效且安全可接受,可能改变全球引产实践。

核心结论

  • 尚待试验结果验证门诊球囊导管引产是否降低剖宫产率并具安全性、成本效果与可接受性。

研究设计与样本

  • 新西兰多中心随机对照试验,足月单胎头位计划引产孕妇随机分为门诊球囊导管组或住院前列腺素E2组。
  • 按1:1比例需纳入1552例,以80%把握度和5%一类错误检出剖宫产率相对下降24%。

关键数值与推荐

  • 主要结局为剖宫产率,基线剖宫产率24.8%,目标相对风险下降24%。
  • 样本量1552例基于80%把握度与5%一类错误计算。

临床怎么用

  • 若结果支持,门诊球囊导管引产可作为以患者为中心的引产护理方案组成部分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Approximately one in four pregnant women undergo an induction of labour. The purpose of this study is to investigate the clinical effectiveness, safety, and cost-effectiveness for mothers and babies of two methods of cervical ripening - inpatient care for women starting induction with vaginal prostaglandin E2 hormones, or allowing women to go home for 18 to 24 h after starting induction with a single-balloon catheter. METHODS/DESIGN: This is a multi-centre randomised controlled trial in New Zealand. Eligible pregnant women, with a live singleton baby in a cephalic presentation who undergo a planned induction of labour at term, will be randomised to outpatient balloon-catheter induction or in-hospital prostaglandin induction. The primary outcome is caesarean section rate. To detect a 24% relative risk reduction in caesarean rate from a baseline of 24.8%, with 80% power and 5% type 1 error, will require 1552 participants in a one to one ratio. DISCUSSION: If outpatient balloon-catheter induction reduces caesarean section rates, has additional clinical benefits, and is safe, cost-effective, and acceptable to women and clinicians, we anticipate change in induction of labour practice around the world. We think that home-based balloon-catheter induction will be welcomed as part of a patient-centred labour-induction care package for pregnant women. TRIAL REGISTRATION: Australia New Zealand Clinical Trials Registry (ANZCTR), ACTRN: 12616000739415. Registered on 6 June 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wise MR, Marriott J, Battin M, et al. Outpatient balloon catheter vs inpatient prostaglandin for induction of labour (OBLIGE): a randomised controlled trial. Trials. 2020. PMID: 32066505. doi:10.1186/s13063-020-4061-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。